Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.4, 2011-01, pp. : 753-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3275-3281

Spandidos Publications

Access to resources Recommend Favorite

Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine

International Journal of Oncology, Vol. 43, Iss. 2, 2013-01 ,pp. : 670-676

Spandidos Publications

Access to resources Recommend Favorite

Astragaloside IV inhibits plateletderived growth factorBBstimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1253-1258

Spandidos Publications

Access to resources Recommend Favorite

ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 977-985

Spandidos Publications

Access to resources Recommend Favorite

Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 603-608

Spandidos Publications

Access to resources Recommend Favorite